|Articles|August 1, 1996

July/August 1996
Volume 2
Issue 7

HEDIS 3.0: Advancing the State of the Art in Health Plan Performance Measurement

Download PDF: HEDIS 3.0: Advancing the State of the Art in Health Plan Performance Measurement

Articles in this issue

about 30 years ago

Article

Correspondence regarding, "Intended and Unintended Consequences of HMO Cost-Containment Strategies: Results from the Managed Care Outcomes Project"

about 30 years ago

Article

Correspondence regarding, "Ethics in Managed Care: The Obligation of Administration to Attending Consequences"

about 30 years ago

Article

Process and Outcome of Outpatient Management of Heart Failure: A Comparison of Cardiologists and Primary Care Providers

about 30 years ago

Article

Understanding the Behavioral Response to Medical Innovation

about 30 years ago

Article

Cost Comparison of Induction of Labor Versus Expectant Management in Pregnancies Lasting Longer Than 41 Weeks

about 30 years ago

Article

Respiratory Syncytial Virus Immune Globulin: A Cost-Effectiveness Analysis

about 30 years ago

Article

Improving Patient Satisfaction with Warfarin Management

about 30 years ago

Article

The Third Generation of Managed Care

about 30 years ago

Article

Results of a Smoking-Cessation Program in a Managed Care Setting

about 30 years ago

Article

Breast Cancer Screening: Who, When, and How

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

HEDIS 3.0: Advancing the State of the Art in Health Plan Performance Measurement

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies